Literature DB >> 30191013

Hepatic stem cells and cancers: a pathologist's view.

Neil D Theise1.   

Abstract

Neil Theise speaks to Georgia Patey, Commissioning Editor: Neil Theise is a diagnostic liver pathologist, adult stem cell researcher and complexity theorist in New York City, where he is a Professor of Pathology at the Mount Sinai Beth Israel Medical Center of Icahn School of Medicine at Mount Sinai. He received his medical degree from Columbia University College of Physicians and Surgeons, where he also received his training in Anatomic Pathology. Subspecialty training was pursued in gastrointestinal (NYU), liver (Royal Free Hospital) and liver transplant (Mount Sinai, NYC) pathology. His earliest research focus was on defining the premalignant dysplastic nodules in human chronic liver disease. He revised understandings of human liver microanatomy, which in turn, led directly to identification of possible liver stem cell niches and the marrow-to-liver regeneration pathway. He is considered a pioneer of multiorgan adult stem cell plasticity. His publications on these topics in model systems and human liver stem cells have been highlighted on a record five covers of Hepatology.

Entities:  

Keywords:  canals of Hering; cancer stem cells; combined hepatocellularcholangiocarcinoma; hepatocellularcarcinoma; liver stem cells

Year:  2015        PMID: 30191013      PMCID: PMC6095186          DOI: 10.2217/hep.15.25

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  12 in total

1.  Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.

Authors: 
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

2.  Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis.

Authors:  Jessica Zucman-Rossi; Jean-Charles Nault; Lars Zender
Journal:  Gastroenterology       Date:  2013-05-29       Impact factor: 22.682

3.  Low hepatocyte repopulation from stem cells: a matter of hepatobiliary linkage not massive production.

Authors:  Neil D Theise; Laurent Dollé; Reiichiro Kuwahara
Journal:  Gastroenterology       Date:  2013-05-31       Impact factor: 22.682

4.  Assessing the potential of induced liver regeneration.

Authors:  George K Michalopoulos; Markus Grompe; Neil D Theise
Journal:  Nat Med       Date:  2013-09       Impact factor: 53.440

5.  The hepatic stem cell niche: identification by label-retaining cell assay.

Authors:  Reiichiro Kuwahara; Alexander V Kofman; Charles S Landis; E Scott Swenson; Els Barendswaard; Neil D Theise
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

6.  Epigenetic reprogramming modulates malignant properties of human liver cancer.

Authors:  Chiara Raggi; Valentina M Factor; Daekwan Seo; Agnes Holczbauer; Matthew C Gillen; Jens U Marquardt; Jesper B Andersen; Marian Durkin; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2014-05-01       Impact factor: 17.425

7.  The canals of Hering and hepatic stem cells in humans.

Authors:  N D Theise; R Saxena; B C Portmann; S N Thung; H Yee; L Chiriboga; A Kumar; J M Crawford
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

8.  Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.

Authors:  So-Mi Yoon; Domniki Gerasimidou; Reiichiro Kuwahara; Prodromos Hytiroglou; Jeong Eun Yoo; Young Nyun Park; Neil D Theise
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

9.  Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Authors:  Ágnes Holczbauer; Valentina M Factor; Jesper B Andersen; Jens U Marquardt; David E Kleiner; Chiara Raggi; Mitsuteru Kitade; Daekwan Seo; Hirofumi Akita; Marian E Durkin; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

10.  Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.

Authors:  Tsunekazu Oikawa; Eliane Wauthier; Timothy A Dinh; Sara R Selitsky; Andrea Reyna-Neyra; Guido Carpino; Ronald Levine; Vincenzo Cardinale; David Klimstra; Eugenio Gaudio; Domenico Alvaro; Nancy Carrasco; Praveen Sethupathy; Lola M Reid
Journal:  Nat Commun       Date:  2015-10-06       Impact factor: 14.919

View more
  2 in total

1.  AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis.

Authors:  Hyunjoo Kim; Muhah Jeong; Do-Hyeong Na; Shin-Hyeon Ryu; Eun Il Jeong; Kwangmin Jung; Jaemin Kang; Ho-June Lee; Taebo Sim; Dae-Yeul Yu; Hee Chul Yu; Baik-Hwan Cho; Yong-Keun Jung
Journal:  Cell Death Dis       Date:  2022-05-18       Impact factor: 9.685

Review 2.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.